Literature DB >> 666606

Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. Six cases from the Middle East and a review of the literature.

W S Risk, F S Haddad, R Chemali.   

Abstract

Of 118 cases of subacute sclerosing panencephalitis identified in an extensive follow-up study in the Middle East, six patients were found by personal interview to have experienced substantial spontaneous long-term improvement. To our knowledge, this rate of 5% for such improvement is presently the most accurate estimate available. Relative to the onset of clinical illness, the conditions of two patients are still improving four to five years later, two are stable four to six years later, one relapsed and died recently after eight years, and one is currently in relapse after 11 years. The condition of five patients had not progressed beyond stage 2 before improvement began. All patients had characteristic clinical and electroencephalographic features. Two patients had brain biopsy specimens showing panencephalitis without inclusions. Five patients had highly elevated levels of serum and CSF measles antibodies. In this article, the course of illness and extent of disability are described, published reports of improvement are reviewed, and the possibility of subclinical illness is discussed.

Entities:  

Mesh:

Year:  1978        PMID: 666606     DOI: 10.1001/archneur.1978.00500320014004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  Subacute sclerosing panencephalitis.

Authors: 
Journal:  Br Med J       Date:  1979-11-03

2.  Unusual features in a case diagnosed as subacute sclerosing panencephalitis (SSPE).

Authors:  K A Flügel; A Barocka; H Woelk
Journal:  J Neurol       Date:  1979-10       Impact factor: 4.849

3.  An evaluation of subacute sclerosing panencephalitis patients with diffusion-weighted magnetic resonance imaging.

Authors:  M Abuhandan; H Cece; M Calik; E Karakas; F Dogan; O Karakas
Journal:  Clin Neuroradiol       Date:  2012-08-12       Impact factor: 3.649

4.  Intraventricular interferon in a case of subacute sclerosing panencephalitis.

Authors:  A Boiardi; S M Baldini; A Sghirlanzoni; R Mancuso; F Corridori
Journal:  Ital J Neurol Sci       Date:  1987-06

5.  Long survival in subacute sclerosing panencephalitis.

Authors:  W A Cobb; J Marshall; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

6.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

7.  Subacute sclerosing panencephalitis in a brother and sister. Therapeutic trial of fibroblast interferon.

Authors:  C R Bartram; J Henke; J Treuner; M Basler; A Esch; W Mortier
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

8.  Identification of a nonproductive, cell-associated form of measles virus by its resistance to inhibition by recombinant human interferon.

Authors:  D R Carrigan; C M Kabacoff
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

9.  Types of immunological failure in the "slow-virus" encephalopathies and multiple sclerosis.

Authors:  J Booss
Journal:  Yale J Biol Med       Date:  1980 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.